Risk Factors of Stroke or Systemic Embolism After Atrial Fibrillation Ablation

NCT03479073 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3198

Last updated 2018-06-18

No results posted yet for this study

Summary

To investigate the rate and risk factors of stroke or systemic embolism (SE) following atrial fibrillation (AF) ablation.

Conditions

Sponsors & Collaborators

  • Hanmi Pharmaceutical Company Limited

    collaborator INDUSTRY
  • Korea University Guro Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-17
Primary Completion
2018-06-14
Completion
2018-06-14

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03479073 on ClinicalTrials.gov